Results 11 to 20 of about 4,471 (213)

Gestational trophoblastic disease in Switzerland: retrospective study of the impact of a regional reference centre

open access: yesSwiss Medical Weekly, 2021
AIMS OF THE STUDY The European Society of Medical Oncology (ESMO) recommends that countries should have reference centres to provide adequate diagnosis and treatment of gestational trophoblastic disease.
Aurore Fehlmann   +12 more
doaj   +1 more source

Comparing and Evaluating Five-Day Chemotherapy Agents Actinomycin D and Methotrexate in Low-Risk Post-Molar Gestational Trophoblastic Neoplasia: A Retrospective Analysis

open access: yesClinical and Experimental Obstetrics & Gynecology, 2022
Background: Low-risk post-molar gestational trophoblastic neoplasia is sensitive to chemotherapy, but there is no consensus regarding the best treatment regimen for low-risk post-molar gestational trophoblastic neoplasia.
Juan Xu, Xinmei Wang, Pengpeng Qu
doaj   +1 more source

Profil Klinikopatologi Pasien Tumor Trofoblas Gestasional yang Dilakukan Operasi di RSUP DR. Hasan Sadikin Bandung Tahun 2017-2020

open access: yesObgynia, 2022
Objective: Knowing the clinical and histopathological proportion of gestational trophoblastic neoplasia patients who underwent surgery. Methods: This study uses a descriptive study design and the data collection using total sampling.
Aviscena Fahmi Ali   +4 more
doaj   +1 more source

Geographical Health District and Distance Traveled Influence on Clinical Status at Admission of Patients with Gestational Trophoblastic Disease

open access: yesRevista Brasileira de Ginecologia e Obstetrícia, 2023
Objective To assess the potential relationship of clinical status upon admission and distance traveled from geographical health district in women with gestational trophoblastic disease (GTD).
Valdete Aparecida Ribeiro da Silva   +7 more
doaj   +1 more source

Placental-site trophoblastic tumor with bone metastasis: A diagnostic and therapeutic challenge

open access: yesGynecologic Oncology Reports, 2023
Placental-site trophoblastic tumor (PSTT) is a rare pathological entity included in the spectrum of gestational trophoblastic neoplasia (GTN). It is a neoplasia with metastatic potential that, once metastasized, has poor prognosis because the tumor tends
Alfredo Ramirez-Espinoza   +5 more
doaj   +1 more source

Epithelioid trophoblastic tumor presenting as a Caesarean scar defect: A case report

open access: yesGynecologic Oncology Reports, 2021
Background: Epithelioid trophoblastic tumor is a rare form of gestational trophoblastic neoplasia. We present the first known case of this rare malignancy presenting as a Caesarean scar defect.
Kristin A. Black   +3 more
doaj   +1 more source

Gestational Trophoblastic Neoplasia

open access: yesCA: A Cancer Journal for Clinicians, 1981
As a result of modern diagnostic and therapeutic techniques, nearly 100 percent of patients with GTN can be cured of a disease thay only a few years ago had a high death rate. To achieve this, skillful mixing of chemotherapy, surgery, and irradiation, as well as supportive therapy, are necessary.
C B, Hammond   +3 more
openaire   +2 more sources

Hydatidiform mole and gestational trophoblastic disease [PDF]

open access: yes, 2009
A mola hidatiforme é uma complicação relativamente infrequente da gravidez, mas com potencial para evolução para formas que necessitam de tratamento sistêmico e podem ser ameaçadoras da vida.
ANDRADE, Jurandyr Moreira de
core   +2 more sources

Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, randomized trial

open access: yesBMC Cancer, 2023
Background Single-agent chemotherapy using methotrexate or actinomycin D is the first-line treatment for patients with low-risk gestational trophoblastic neoplasia.
Fang Jiang   +10 more
doaj   +1 more source

臨床的侵入奇胎における5-day MTX療法およびETP療法による治療効果と5-dayMTX療法における薬剤耐性の早期予測因子 [PDF]

open access: yes, 2017
博士(医学) 乙第2959号(主論文の要旨、要約、審査結果の要旨、本文),著者名:Shoko KIZAKI・Kazunori HASHIMOTO・Hideo MATSUI・Hirokazu USUI・Makio SHOZU,タイトル:Comparison of 5-day MTX and 5-day ETP treatment results and early predictors of drug resistance to 5-day MTX in patients with post-molar ...
木崎 尚子
core   +2 more sources

Home - About - Disclaimer - Privacy